/PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced patients have been dosed in the world’s first study of a potential antibody treatment…
Categories
/PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced patients have been dosed in the world’s first study of a potential antibody treatment…